Analysts fell to the sidelines weighing in on Sumitomo Dainippon Pharma Co (DNPUF – Research Report) and Sanofi (SNYNF – Research Report) with ...

UK-based Exscientia has been working with Japanese pharma Sumitomo Dainippon Pharma (DSP) on the drug for obsessive-compulsive disorder (OCD), and the trial aims to measure its efficacy.

The new molecule – called DSP-0038 – is being developed by Japan's Sumitomo Dainippon Pharma (DSP), which is now starting a phase 1 trial in the US as a treatment for psychosis associated with ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...

Japan is one of the Asian countries that is aging quickly. In June 2019, Sumitomo Dainippon Pharma Co. Ltd. modified its contract with Healios K.K. for joint development initiatives and other ...

Roivant sold its stake in five subsidiaries to Sumitomo Dainippon Pharma, giving Vivek Ramaswamy a gain of USD 175 million. In 2022, as soon as his Rahu dasha ended and the Jupiter dasha began ...

Sumitomo Pharma, formerly Sumitomo Dainippon Pharma Co Ltd, develops, manufactures, sells, imports and exports pharmaceutical products. The company drugs are focused on major therapeutic areas which ...

Professor of Psychiatry and Molecular Medicine, Department of Psychiatry; Hofstra North Shore Long Island School of Medicine, Hempstead, New York; Medical Director, Recognition and Prevention ...

HW reports research funds from Kyowa Kirin in relation to this work, and honoraria from Takeda Pharmaceutical, AbbVie, Kyowa Kirin, Sumitomo Dainippon Pharma, Novartis, Otsuka Pharmaceutical, and FP ...